piperaquine has been researched along with Infections, Plasmodium in 186 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (8.06) | 18.7374 |
| 1990's | 3 (1.61) | 18.2507 |
| 2000's | 14 (7.53) | 29.6817 |
| 2010's | 99 (53.23) | 24.3611 |
| 2020's | 55 (29.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ager, AL; Andersen, SL; Ellis, WY; Gerena, L; Milhous, WK; Vennerstrom, JL | 1 |
| Andrzejewski, C; Batty, KT; Ilett, KF; Jago, JD; Moore, BR; Page-Sharp, M | 1 |
| Becker, K; Davioud-Charvet, E; Friebolin, W; Furrer, J; Jannack, B; Lanzer, M; Oeser, T; Sanchez, CP; Wenzel, N; Yardley, V | 1 |
| Anstey, NM; Chalfein, F; Ebsworth, EP; Kenangalem, E; Marfurt, J; Piera, KA; Prasetyorini, B; Price, RN; Ratcliff, A; Russell, B; Siswantoro, H; Tjitra, E; Wuwung, M | 1 |
| Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
| Bane, CE; Black, C; Butler, K; Caridha, D; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Huezo, SJ; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Nolan, C; Olmeda, R; Potter, B; Pou, S; Rasmussen, SA; Read, L; Riscoe, MK; Roncal, N; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Stephens, MT; Tan, JC; Vesely, B; Vuong, C; Winter, RW; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
| Ashton, TD; Burrows, JN; Charman, SA; Creek, DJ; Devine, SM; Laleu, B; Möhrle, JJ; Sleebs, BE | 1 |
| Cheong, SL; Ng, CH; Tibon, NS | 1 |
| Bane, CE; Bayles, BR; Black, C; Butler, K; Caridha, D; Ceja, FG; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Mu, J; Nolan, C; Olmeda, R; Potter, B; Pou, S; Pybus, B; Rasmussen, SA; Read, L; Reynolds, KA; Riscoe, MK; Roncal, N; Rosenthal, PJ; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Tumwebaze, PK; Vesely, B; Vuong, C; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
| Baguma, E; Boyce, RM; Brown-Marusiak, A; Goel, V; Hollingsworth, BD; Juliano, JJ; Muhindo, R; Mulogo, EM; Ntaro, M; Reyes, R; Siedner, MJ; Staedke, SG; Xu, E | 1 |
| Dimessa, LB; El Gaaloul, M; Esen, M; Garcia-Otero, L; González, R; Lagler, H; Lell, B; Menendez, C; Mischlinger, J; Mombo-Ngoma, G; Nhampossa, T; Piqueras, M; Pons-Duran, C; Ramharter, M; Sanz, S; Saute, F; Sevene, E; Tchouatieu, AM; Zoleko Manego, R | 1 |
| Aweeka, F; Clark, TD; Dorsey, G; Hughes, E; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Ochieng, T; Rosenthal, PJ; Savic, RM; Wallender, E | 1 |
| Achan, J; Bousema, T; Bradley, J; Broekhuizen, H; Ceesay, F; Conteh, B; D'Alessandro, U; Dabira, ED; Drakeley, C; Kandeh, B; Lindsay, SW; Mohammed, N; Ndiath, MO; Peeters Grietens, K; Slater, H; Smit, MR; Soumare, HM | 1 |
| Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G | 1 |
| Allen, E; Banda, CG; Barnes, KI; Chirwa, M; Kapulula, M; Maartens, G; Madanitsa, M; Munharo, S; Muyaya, S; Mwapasa, V; Nkosi, D; Phiri, KS; Ter Kuile, FO; Wiesner, L; Workman, L | 1 |
| Attaher, O; Bousema, T; Bradley, J; Diallo, M; Dicko, A; Dicko, OM; Drakeley, C; Issiaka, D; Keita, S; Lanke, K; Maguiraga, SO; Mahamar, A; McCall, MBB; Niambele, SM; Sacko, A; Samake, S; Sanogo, K; Sinaba, Y; Smit, MJ; Stone, W; Ter Heine, R; Traore, SF | 1 |
| Siahaan, L | 1 |
| Bruschi, F; Fabiani, S; L'Episcopia, M; Mangano, V; Motta, V; Severini, C; Sparavelli, R; Verdenelli, S | 1 |
| Abdallah, KS; Bacar, A; Deng, C; Li, G; Li, M; Liu, R; Lu, C; Silai, R; Song, J; Tan, R; Wu, W; Xu, Q; Yuan, Y; Zhang, H; Zheng, S | 1 |
| Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N | 1 |
| Clapp, S; Freedman, B; Green, CL; Kirui, JK; Korwa, S; Njuguna, FM; O'Meara, WP; Taylor, SM; Wu, A | 1 |
| Cahyaningsih, U; Maring, AJ; Nugraha, AB; Sa'diah, S; Sari, RK; Syafii, W | 1 |
| Allen, E; Banda, CG; Barnes, KI; Chirwa, M; Kapulula, M; Maartens, G; Madanitsa, M; Munharo, S; Muyaya, S; Mwapasa, V; Nkosi, D; Phiri, KS; Tarning, J; Ter Kuile, FO; Workman, L | 1 |
| Bousema, T; Bradley, J; Camara, MM; Ceesay, S; Conteh, B; D'Alessandro, U; Dabira, ED; Drakeley, C; Erhart, A; Gaye, PM; Jadama, L; Jawara, EA; Kanteh, S; Lindsay, SW; Mohammed, N; Ndiath, MO; Njie, AK; Ooko, M; Sanneh, F; Soumare, HM | 1 |
| Assefa, A; Bekele, W; Chernet, M; Commons, RJ; Etana, K; Gidey, B; Girma, S; Gubae, K; Haile, M; Hailgiorgis, H; Mohammed, H; Sime, H; Solomon, H; Tasew, G; Tollera, G | 1 |
| Baraka, V; Chacky, F; Challe, DP; Chiduo, M; David, A; Francis, F; Gesase, S; Kamugisha, M; Lazaro, S; Liheluka, E; Lusasi, A; Lusingu, JPA; Makenga, G; Mandara, C; Mhina, A; Minja, DTR; Mmbando, BP; Mohamed, A; Molteni, F; Mtove, G; Nkayamba, A; Segeja, M; Seth, MD; Thawer, S; Van Geertruyden, JP | 1 |
| Abuaku, B; Amoako, EO; Asamoah, A; Boateng, P; Duah-Quashie, NO; Koram, KA; Malm, KL; Matrevi, SA; Owusu-Antwi, F; Peprah, NY; Quashie, N | 1 |
| Amoah, B; Bukenya, F; Colborn, K; Echodu, DC; Eganyu, T; Elliott, RC; Giorgi, E; Gonahasa, S; Kilama, M; Mulebeke, R; Nankabirwa, J; Odude, W; Omoding, O; Opigo, J; Powell, SE; Roskosky, M; Wanzira, H; Yeka, A | 1 |
| Akinola, O; Amusan, AI; Ategbero, E; Gbotosho, GO | 1 |
| Akun, P; Galileya, LT; Idro, R; Kalibbala, D; Nambatya, W; Nkosi-Gondwe, T; Opoka, R; Phiri, K; Robberstad, B; Rujumba, J; Ssenkusu, J; TerKuile, F | 1 |
| Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K | 1 |
| Baird, JK; Berni, A; Budiman, W; Cedar, E; Chand, K; Crenna-Darusallam, C; Duparc, S; Ekawati, LL; Elyazar, I; Fernando, D; Fletcher, K; Goyal, N; Green, JA; Instiaty, I; Jones, S; Kleim, JP; Lardo, S; Martin, A; Noviyanti, R; Prasetya, CB; Rolfe, K; Santy, YW; Satyagraha, AW; Sharma, H; Soebandrio, A; Subekti, D; Sutanto, I; Tan, LK; Taylor, M | 1 |
| Arcelia, F; Pasaribu, AP; Yanni, GN | 1 |
| Eisenberg, SL; Krieger, AE | 1 |
| Baraka, V; Francis, F; Geertruyden, JV; Gesase, S; Kyaruzi, E; Lusingu, JPA; Madebe, R; Makenga, G; Minja, DTR; Mtove, G; Nakato, S | 1 |
| Asih, PBS; Basri, HH; Bustos, MDG; Charunwatthana, P; Dewayanti, FK; Dondorp, AM; Imwong, M; Permana, DH; Prameswari, HD; Rahmasari, FV; Risandi, R; Rozi, IE; Syafruddin, D; Syahrani, L; Wangsamuda, S | 1 |
| Abebe, A; Ahmedin, M; Atim, MG; Embaye, SM; Kahabuka, M; Kazembe, D; Manyazewal, T; Mesfin, T; Muthoka, EN; Namuganza, S; Usmael, K | 1 |
| Bukenya, F; Collborn, K; Echodu, D; Eganyu, T; Elliot, R; Mulebeke, R; Van Geertruyden, JP; Wanzira, H; Yeka, A | 1 |
| Chandler, CIR; Dorsey, G; Drakeley, C; Gonahasa, S; Kamya, MR; Kigozi, SP; Maiteki-Sebuguzi, C; Okiring, J; Rehman, AM; Staedke, SG | 1 |
| Davidson, SA; Day, NPJ; Dondorp, A; Hanboonkunupakarn, B; Hoglund, RM; Jittamala, P; Kobylinski, KC; Mukaka, M; Pantuwatana, K; Phasomkusolsil, S; Pukrittayakamee, S; Tarning, J; van der Pluijm, RW; White, NJ; Winterberg, M | 1 |
| Ahmad, RA; Kenangalem, E; Laksono, IS; Lampah, DA; Murhandarwati, EEH; Poespoprodjo, JR; Sikora, SA; Sugiarto, P | 1 |
| Aljayyoussi, G; Alout, H; Bousema, T; Burrows, J; Chaccour, C; D'Alessandro, U; Foy, BD; Ghani, AC; Hellewell, J; Kobylinski, K; Slater, HC; Smit, MR; Ter Kuile, FO; Walker, PGT; Watson, OJ | 1 |
| D'Hoore, W; Kiguba, R; Kirabira, E; Manirakiza, L; Mukonzo, J; Nabirye, L; Ndagije, HB; Olsson, S; Speybroeck, N; Spinewine, A; Sserwanga, A | 1 |
| Abdulla, S; Adjei, A; Adjuik, M; Asante, KP; Baiden, R; Binka, F; Compaore, G; Day, NPJ; Gyapong, M; Kabanywanyi, AM; Macete, E; Oduro, A; Ogutu, B; Osei, I; Owusu-Agyei, S; Sevene, E; Sie, A; Tarning, J; Tinto, H; Valea, I; Wattanakul, T; White, NJ; Winterberg, M | 1 |
| Aide, P; Alonso, PL; Bassat, Q; Chidimatembue, A; Cisteró, P; Galatas, B; Gupta, H; Huijben, S; Matambisso, G; Mayor, A; Ménard, D; Nhamussua, L; Rabinovich, NR; Ringwald, P; Saúte, F; Simone, W | 1 |
| Desai, M; Dorsey, G; Fernandes, S; Gutman, J; Hanson, K; Kakuru, A; Kamya, MR; Kariuki, S; Ter Kuile, FO; Were, V | 1 |
| Ahmed, R; Ansariadi, A; Bonsapia, I; Burdam, FH; Hill, J; Khairallah, C; Paintain, L; Rini Poespoprodjo, J; Syafruddin, D; Ter Kuile, FO; Umbu Reku Landuwulang, C; Webster, J | 1 |
| Bruce, J; Desai, M; Hill, J; Kariuki, S; Oluoch, S; Ouma, P; Webster, J | 1 |
| Boele van Hensbroek, M; Desai, MR; Dhabangi, A; Idro, R; John, CC; Kariuki, S; Kuya, NA; Kwambai, TK; Onyango, ED; Opoka, R; Otieno, K; Phiri, KS; Robberstad, B; Samuels, AM; Ter Kuile, FO; Wang, D; Watson, V | 1 |
| Ahmed, R; Asih, PBS; Chotsiri, P; Desai, M; Gutman, JR; Kariuki, S; Katana, A; Khairallah, C; L'lanziva, A; Otieno, K; Ouma, P; Poespoprodjo, JR; Price, RN; Syafruddin, D; Tarning, J; Ter Kuile, FO; Were, V | 1 |
| Achan, J; D'Alessandro, U; de Vries, D; Grietens, KP; Gryseels, C; Jaiteh, F; Masunaga, Y; Okebe, J; Ribera, JM | 1 |
| Baker, M; Hoglund, RM; McCarthy, JS; McWhinney, B; Mohrle, J; Tarning, J; Wattanakul, T | 1 |
| Hafid, AF; Ilmi, H; Prasetyo, B; Tumewu, L; Widyawaruyanti, A | 1 |
| Akello, F; Amongi, S; Amongin, R; Cose, S; Elliott, AM; Kabuubi, PN; Kiwanuka, S; Kiwudhu, F; Kizindo, R; Mutebe, A; Nakazibwe, E; Nassuuna, J; Natukunda, A; Nkurunungi, G; Nsubuga, D; Oduru, G; Onen, C; Sewankambo, M; Staedke, SG; Webb, E; Zirimenya, L | 1 |
| Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C | 1 |
| Andersen, JF; Coonahan, ES; De Vos, M; Fay, MP; Long, CA; Pecic, S; Tarning, J; Wellems, TE; Yang, KA | 1 |
| Hughes, E; Jagannathan, P; Mohamed Ali, A; Savic, RM; Wallender, E | 1 |
| Aklillu, E; Kamuhabwa, AAR; Minzi, O; Mlugu, EM | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Baltzell, K; Benjamin-Chung, J; Bhangu, K; Dlamini, B; Dlamini, N; Dufour, MK; Gosling, R; Greenhouse, B; Helb, D; Hsiang, MS; Kalungero, M; Kunene, S; Malambe, C; Maphalala, G; Mngadi, N; Nhlabathi, N; Ntshalintshali, N; Pindolia, D; Prach, LM; Tesfa, G; Vilakati, S; Whittemore, B | 1 |
| Andronescu, LR; Chinkhumba, J; Gutman, JR; Kachepa, W; Kachingwe, M; Laufer, MK; Liang, Y; Mathanga, DP; Peterson, I; Sharma, A | 1 |
| Hirai, M; Ikeda, M; Mita, T; Mori, T; Tachibana, SI | 1 |
| Esu, EB; Meremikwu, MM; Oringanje, C | 1 |
| Abega, F; Ayong, L; Berry, A; Gandia, P; Iriart, X; Khim, N; Lanot, T; Mairet-Khedim, M; Menard, S; Morlais, I; Ngou, C; Nsango, S; Otam, L; Roesch, C; Srun, S; Witkowski, B | 1 |
| Ategeka, J; Charlebois, ED; Clark, TD; Cohan, D; Dorsey, G; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Koss, CA; Muehlenbachs, A; Muhindo, M; Nakalembe, M; Natureeba, P; Nzarubara, B; Ochieng, T; Plenty, A; Rizzuto, G; Ruel, T | 1 |
| Delaval, P; Desrues, B; Fourmont, L; Jouneau, S; Lederlin, M; Polard, E; Revest, M; Tattevin, P | 1 |
| Buyze, J; D'Alessandro, U; Hachizovu, S; Kabuya, JB; Kasongo, W; Mulenga, J; Mulenga, M; Mwakazanga, D; Nambozi, M; Van Geertruyden, JP | 1 |
| Bouhenia, M; Coldiron, ME; Das, D; Elder, G; Grais, RF; Langendorf, C; Lasry, E; Mwanga, J; Nyehangane, D; Okui, P; Salumu, L | 1 |
| Affara, M; Bei, AK; Deme, AB; Dieye, B; Diongue, K; Gaye, A; Koita, O; Krogstad, DJ; Mbaye, A; Ndiaye, D; Ndiaye, IM; Ndiaye, T; Ndiaye, YD; Nwakanma, D; Sy, M; Sy, N; Volkman, S; Yade, MS | 1 |
| Clark, RL | 1 |
| Badhan, RKS; Coleman, M; Olafuyi, O | 1 |
| Aweeka, FT; Jagannathan, P; Kajubi, R | 1 |
| Srinivas, NR | 1 |
| Rabinovich, NR | 1 |
| Chandler, CIR; Dorsey, G; Drakeley, C; Gonahasa, S; Kamya, MR; Kigozi, SP; Lindsay, SW; Maiteki-Sebuguzi, C; Okiring, J; Rehman, AM; Staedke, SG | 1 |
| Bassat, Q; Millat-Martínez, P | 1 |
| Brugada, J; Chan, XHS; Mawer, LJ; Tan, JY; White, NJ; Win, YN | 1 |
| Kamara, ARY; Menard, D; Sahr, F; Samai, M; Smith, SJ; Swaray, AS; Warsame, M | 1 |
| Bernigaud, C; Chosidow, O; Do-Pham, G | 1 |
| Aol, G; Bigogo, GM; Desai, M; Hill, J; Laserson, KF; Phillips-Howard, PA; Taegtmeyer, M; Ter Kuile, F; Young, N | 1 |
| Blomberg, B; Gondwe, T; Lange, S; Mukaka, M; Phiri, K; Robberstad, B | 1 |
| Abong'o, BO; Aljayyoussi, G; Bayoh, NM; Bousema, T; Desai, MR; Gimnig, JE; Kariuki, SK; Kwambai, TK; Ochomo, EO; Phillips-Howard, PA; Samuels, AM; Smit, MR; Ter Kuile, FO; Wang, D; Ward, SA; Waterhouse, D | 1 |
| Cen, YZ; Deng, ZH; Li, XH; Liao, YB; Lin, RX; Liu, MR; Pan, B; Pei, FQ; Ren, WF; Ruan, CW | 1 |
| Abel, H; Bassat, Q; Ila, R; Karunajeewa, H; Laman, M; Manning, L; Millat-Martínez, P; Mitjà, O; Moore, B; Pulai, K; Robinson, L; Sanz, S | 1 |
| Guler, JL; Rosenthal, PJ | 1 |
| Achan, J; Affara, M; Bousema, T; D'Alessandro, U; di Tanna, GL; Dierickx, S; Drakeley, C; Kanuteh, F; Mohammed, NI; Mwesigwa, J; Nwakanma, D; Prom, A; Van Geertruyden, JP; Wathuo, M; Worwui, A | 1 |
| Desai, M; Dhabangi, A; Idro, R; John, CC; Kariuki, S; Kwambai, TK; Opoka, R; Phiri, K; Robberstad, B; Samuels, AM; Ter Kuile, FO; van Hensbroek, MB; Wang, D | 1 |
| Ali, AS; Ali, SM; Aydin-Schmidt, B; Bennett, A; Björkman, A; Hodzic, L; Islam, A; Jovel, I; Khamis, M; Magnusson, E; Mårtensson, A; Mkali, H; Morris, U; Msellem, MI; Poirot, E; Sachs, MC; Shija, SJ; Tarning, J | 1 |
| Blomberg, B; Lange, S; Nkosi-Gondwe, T; Phiri, KS; Robberstad, B | 1 |
| Bangirana, P; Conroy, AL; Dorsey, G; Jagannathan, P; John, CC; Kakuru, A; Kamya, MR; Liechty, EA; Muhindo, MK; Nakalembe, M; Opoka, RO | 1 |
| Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P | 1 |
| Balen, J; Bradley, J; D'Alessandro, U; Grietens, KP; Gryseels, C; Jaiteh, F; Masunaga, Y; Okebe, J; Ribera, JM | 1 |
| Hakizimana, D; Kabera, M; Kayobotsi, C; Mbituyumuremyi, A; Munyaneza, T; Murindahabi, M; Musanabaganwa, C; Muvunyi, CM; Nisingizwe, MP; Ntagwabira, E; Penkunas, MJ; Umulisa, N; Uwimana, A; Uyizeye, D; Warsame, M | 1 |
| Laufer, MK | 1 |
| Chau Ngo, TM; Dinh Huynh, C; Fiori, PL; Giang Phan, TH; Hanh Nguyen, TL; Hoang, H; Low, PS; Marchetti, G; Pantaleo, A; Pau, MC; Schwarzer, E; Ton Nu, PA; Tsamesidis, I; Tuan Tran, A; Turrini, FM | 1 |
| Esu, E; Meremikwu, M; Oduwole, O; Okusanya, BO; Olaleye, A | 1 |
| Garrido Jareño, M; Otero Reigada, MDC; Peman García, J; Ramírez Cuentas, JH; Roselló Guijarro, M; Urtasun Erburu, A | 1 |
| Cohee, LM; Laufer, MK | 1 |
| Guo, H; Huang, X; Lu, F; Ye, Z; Yi, G; Zhou, L | 1 |
| Cano, J; Chico, RM | 1 |
| Arinaitwe, E; Aweeka, FT; Bigira, V; Creek, DJ; Kakuru, A; Lindegardh, N; McCormack, S; Nosten, F; Parikh, S; Sandison, TG; Tappero, JW; Wanzira, H | 1 |
| Poll, EM; Ubben, D | 1 |
| Ariey, F; Beck, HP; Buclin, T; Csajka, C; Decosterd, LA; Duong, S; Genton, B; Guidi, M; Kabanywanyi, AM; Mercier, T; Olliaro, P; Staehli Hodel, EM; Zanolari, B | 1 |
| Doua, JY; Lutumba, P; Matangila, J; Van Geertruyden, JP | 1 |
| Amuge, P; Brooker, SJ; Dorsey, G; Kamya, MR; Kiwanuka, N; Nankabirwa, JI; Rosenthal, PJ; Staedke, SG; Wandera, B | 1 |
| Hastings, IM; Hayes, DJ; Hodel, EM; Kay, K; Terlouw, DJ | 1 |
| Borrmann, S; Pfeil, J; Tozan, Y | 1 |
| Achan, J; Arinaitwe, E; Charlebois, E; Clark, TD; Dorsey, G; Havlir, D; Ikilezi, G; Kakuru, A; Kamya, MR; Muhindo, MK; Mwangwa, F; Rosenthal, PJ; Ruel, T; Tappero, JW | 1 |
| Batty, KT; Gibbons, PL; Kirkpatrick, CM; Moore, BR; Patel, K | 1 |
| Batty, KT; Benjamin, JM; Davis, TM; Ginny, E; Griffin, S; Moore, BR; Mueller, I; Page-Sharp, M; Robinson, LJ; Salman, S; Siba, P | 1 |
| Auayporn, M; Buathong, N; Cantilena, L; Chann, S; Chour, CM; Haigney, M; Kaewkungwal, J; Kuntawunginn, W; Lanteri, C; Lon, C; Manning, J; Mitprasat, M; Phann, ST; Prom, S; Saunders, D; Se, Y; Sea, D; Siripokasupkul, R; So, M; Soh, E; Somethy, S; Spring, M; Sriwichai, S; Tang, D; Teja-Isavadharm, P; Timmermans, A; Vanachayangkul, P | 1 |
| Achan, J; Aweeka, FT; Bigira, V; Clark, TD; Dorsey, G; Havlir, DV; Huang, L; Kamya, MR; Kapisi, J; Kinara, S; Muhindo, MK; Mwangwa, F; Osterbauer, B; Rosenthal, PJ | 1 |
| Borrmann, S; Heiss, K; Meister, M; Mueller, AK; Pfeil, J; Sepp, KJ | 1 |
| Mori, AT; Ngalesoni, F; Norheim, OF; Robberstad, B | 1 |
| Bergstrand, M; Karlsson, MO; Lwin, KM; Nosten, F; Tarning, J; White, NJ | 1 |
| Achan, J; Aweeka, FT; Bigira, V; Clark, TD; Dorsey, G; Havlir, DV; Huang, L; Jagannathan, P; Kakuru, A; Kamya, MR; Kapisi, J; Kinara, S; Muhindo, MK; Mwangwa, F; Rosenthal, PJ | 1 |
| Claeys, Y; D'Alessandro, U; De Crop, M; Halidou, T; Kalanda, G; Menten, J; Mulenga, M; Mutabingwa, T; Mwakazanga, D; Mwapasa, V; Nambozi, M; Phiri, LK; Ravinetto, R; Schurmans, C; Tagbor, H; Thriemer, K; Traore, M; Valea, I; Van Geertruyden, JP | 1 |
| Ewing, VL; Kapinda, A; Lalloo, DG; Pace, C; Richards, E; Terlouw, DJ; Tolhurst, R | 1 |
| Burugu, MW; Gimode, WR; Kiboi, DM; Kimani, FT; Muregi, FW; Wamakima, HN | 1 |
| Arinaitwe, E; Aweeka, FT; Bigira, V; Creek, DJ; Kakuru, A; Lindegardh, N; McCormack, SA; Nosten, F; Parikh, S; Sambol, NC; Tappero, JW; Tarning, J; Wanzira, H; Yan, L | 1 |
| Abdulla, S; Adjei, A; Adjuik, M; Akparibo, R; Baiden, R; Binka, F; Compaoré, G; Gyapong, M; Halidou, T; Macete, E; Mulokozi, A; Oduro, A; Ogutu, B; Osei, I; Owusu-Agyei, S; Sevene, E; Sie, A; Smith, P; Upunda, GL; Valea, I; Yawson, A | 1 |
| Compaore, YD; Greenwood, B; Milligan, P; Nosten, F; Ouedraogo, JB; Rosenthal, PJ; Some, AF; Sutherland, C; Tarning, J; Zongo, I | 1 |
| Anstey, NM; Fobia, W; Kenangalem, E; Lampah, DA; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E | 1 |
| Casteras, J; Dhingra, SK; Fidock, DA; Gabryszewski, SJ; Legrand, E; Moss, EL; Musset, L; Neafsey, DE; Pelleau, S; Volkman, SK; Volney, B; Wirth, DF | 1 |
| Bennett, A; Chalwe, V; Eisele, TP; Finn, T; Hamainza, B; Kamuliwo, M; Keating, J; Miller, JM; Moonga, H; Silumbe, K; Steketee, RW; Yukich, J | 1 |
| Aweeka, F; Bigira, V; Dorsey, G; Huang, L; Jagannathan, P; Kakuru, MM; Kamya, MR; Kapisi, J; Savic, R; Sundell, K | 1 |
| Desai, M; Gutman, J; Juma, E; Kariuki, S; Katana, A; L'lanziva, A; Laserson, K; Otieno, K; Ouma, P; ter Kuile, FO; Were, V; Williamson, J | 1 |
| Mori, AT; Norheim, OF; Robberstad, B | 1 |
| Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
| Anvikar, AR; Arora, S; Iyer, SS; Jalali, RK; Mishra, P; Rao, BS; Roy, A; Rulisa, S; Saha, N; Sharma, P; Toure, OA; Valecha, N | 1 |
| Anvikar, AR; Arora, S; Gogtay, N; Iyer, SS; Jalali, RK; Kochar, SK; Kumar, NB; Lakhani, JD; Rajadhyaksha, GC; Rao, BH; Roy, A; Saha, N; Savargaonkar, D; Sharma, P; Solanki, BB; Srivastava, B; Tripathi, SK; Valecha, N | 1 |
| Abdulla, S; Adjei, A; Adjuik, M; Amu, A; Asante, KP; Baiden, R; Binka, F; Compaore, G; Gyapong, M; Halidou, T; Kukula, V; Macete, E; Mulokozi, A; Nagai, RA; Narh-Bana, S; Oduro, A; Ogutu, B; Osei, I; Owusu-Agyei, S; Sevene, E; Sie, A; Valea, I | 1 |
| Bannister-Tyrell, M; D'Alessandro, U; Dierickx, S; Gerrets, R; Grietens, KP; Gryseels, C; Jaiteh, F; Mwesigwa, J; O'Neill, S; Ronse, M | 1 |
| Maxmen, A | 1 |
| Ategeka, J; Awori, P; Charlebois, ED; Clark, TD; Dorsey, G; Feeney, ME; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muehlenbachs, A; Muhindo, MK; Nakalembe, M; Natureeba, P; Nayebare, P; Olwoch, P; Opira, B; Rizzuto, G | 1 |
| Achieng, F; Desai, M; Hill, J; Hoyt, J; Kariuki, S; L'lanziva, A; Ouma, P; Webster, J | 1 |
| Arinaitwe, E; Parikh, S; Sambol, NC; Tappero, JW | 1 |
| Ali, D; Faragher, B; Kalilani, L; Kang'ombe, A; Khairallah, C; Levitt, B; Madanitsa, M; Meshnick, S; Mwapasa, V; Pace, C; Smedley, J; Taylor, SM; Ter Kuile, FO; Thwai, KL; van Eijk, AM; Wang, D | 1 |
| Elvina, E; Kajeechiwa, L; Kyawt, K; Min, JR; Nosten, F; Nosten, S; Oo, PT; Peapah, P; PoWah, W; Shee, PW; Thwin, MM; von Seidlein, L; Wiladphaingern, J; Yee, NL | 1 |
| Abdulla, S; Adjei, A; Adjuik, M; Akparibo, R; Ali, AM; Baiden, R; Binka, F; Compaoré, G; Gyapong, M; Kabanywanyi, AM; Kakolwa, MA; Macete, E; Mahende, MK; Oduro, A; Ogutu, BR; Osei, I; Owusu-Agyei, S; Sevene, E; Sie, A; Tinto, H; Valea, I; Yawson, A | 1 |
| Dorsey, G; Gutman, J; Kovacs, S; Stergachis, A; Ter Kuile, FO | 1 |
| Sullivan, DJ; Walker, LA | 1 |
| da Luz, RI; Doua, JY; Lutumba, P; Matangila, JR; Mitashi, P; Van Geertruyden, JP | 1 |
| Aweeka, FT; Chamankhah, N; Dorsey, G; Havlir, D; Huang, L; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, M; Koss, CA; Mwebaza, N; Rosenthal, PJ; Ruel, T; Were, M | 1 |
| Dorsey, G; Nosten, F; Price, RN | 1 |
| Abiodun, O; Bell, A; Brun, R; Chollet, J; Irungu, BN; Kiboi, DM; Langat, B; Nganga, JK; Nyambati, VC; Nzila, A; Rukunga, GM; Wittlin, S | 1 |
| Batty, KT; Ilett, KF; Jago, JD; Moore, BR; Page-Sharp, M | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| D'alessandro, U | 1 |
| Cairns, M; Cames, C; Cheng, Y; Cisse, B; Faye, B; Faye, E; Faye, O; Gaye, O; Greenwood, B; Lô, AC; Milligan, P; NDiaye, JL; NDiaye, M; NDiaye, O; Simondon, K; Trape, JF | 1 |
| Bacchieri, A; Bassat, Q; Borrmann, S; Corsi, M; D'Alessandro, U; Menéndez, C; Mulenga, M; Nabasumba, C; Nambozi, M; Piola, P; Sasi, P; Talisuna, A; Tinto, H; Ubben, D; Valéa, I | 1 |
| Arinaitwe, E; Bigira, V; Creek, D; Dorsey, G; Kakuru, A; Kamya, MR; Sandison, TG; Tappero, J; Wanzira, H | 1 |
| Arinaitwe, E; Bigira, V; Dorsey, G; Kakuru, A; Kamya, M; Sandison, T; Tappero, JW; Verret, WJ; Wanzira, H | 1 |
| Adjalley, SH; Eappen, AG; Eastman, RT; Ekland, EH; Fidock, DA; Hoffman, SL; Johnston, GL; Lee, MC; Li, T; Richman, A; Sim, BK | 1 |
| Day, NP; Hanpithakpong, W; Lindegardh, N; McGready, R; Nosten, F; Phyo, AP; Rijken, MJ; Tarning, J; White, NJ | 1 |
| Batty, KT; Davis, TM; Griffin, S; Ilett, KF; Kose, K; Mueller, I; Page-Sharp, M; Salman, S; Siba, PM | 1 |
| Amansyah, F; Dedang, TA; Driyah, S; Ekowatiningsih, R; Hasugian, AR; Januar, L; Labora, J; Prasetyorini, B; Purnama, A; Purnamasari, T; Salwati, E; Siswantoro, H; Tjitra, E; Wijayanto, B; Yusnita, EA; Yuwarni, E | 1 |
| Chavchich, M; Dai, B; Edstein, MD; Phong, NC; Quang, HH; Shanks, GD; Thanh, NX; Trung, TN | 1 |
| D'Alessandro, U; Donegan, S; Tudur Smith, C; Williamson, P | 1 |
| Guo, H; Huang, XX; Pan, ZY; Wu, JY; Xue, WL; Yi, GH; Zhou, LM | 1 |
| Aung, K; Mak, JW; Naing, C; Wong, JY | 1 |
| Ariey, F; Beck, HP; Csajka, C; Decosterd, LA; Duong, S; Genton, B; Guidi, M; Kabanywanyi, AM; Olliaro, P; Staehli Hodel, EM | 1 |
| Baird, JK; Basri, H; Ekawati, LL; Elyazar, I; Farrar, J; Meilia, RA; Nurleila, S; Putri, FA; Setiabudy, R; Sudoyo, H; Sutanto, I; Taylor, WR; Tjahjono, B | 1 |
| Davis, TM; Hung, TY; Ilett, KF; Karunajeewa, HA; Sim, IK | 1 |
| Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
| Anstey, NM; Ebsworth, EP; Hasugian, AR; Kenangalem, E; Laihad, F; Lindegardh, N; Penttinen, P; Price, RN; Purba, HL; Ratcliff, A; Siswantoro, H; Tjitra, E | 1 |
| Lindegardh, N; Tarning, J | 1 |
| Coulanges, P; Deloron, P; Le Bras, J; Ramanamirija, JA; Verdier, P | 1 |
| Coulanges, P; Deloron, P; Ramanamirija, JA; Verdíer, F | 1 |
| Coulanges, P; Deĺoron, P; Le Bras, J; Ramanamirija, JA | 2 |
| Dai, ZR; Jiang, ZK; Li, JC; Zhu, DQ | 1 |
| Qu, FY | 1 |
| Chen, L; Qu, FY; Zhou, YC | 1 |
| Chen, C; Chen, L; Dai, ZR; Ma, ZM; Zheng, XY | 1 |
| Chen, L; Li, G; Lu, Y; Luo, Z | 1 |
| Chen, L | 1 |
| Chen, L; Dai, ZR; Fu, DD; Guo, FC; Liao, ZH; Ma, DQ; Ma, ZM; Pang, XJ; Qian, YL | 1 |
| Chen, YS; Guo, RN; Huang, ZS; Lan, CX; Lin, X | 1 |
| Fu, LC; Guo, XB | 1 |
| Chen, L; Dai, ZR; Li, CJ; Qian, YL | 1 |
| Biaud, JM; Coulanges, P; Deloron, P; Le Bras, J; Ramanamirija, JA | 1 |
| Li, GD | 1 |
| Huang, JZ; Lan, XH; Xu, WZ | 1 |
| Wu, Z | 1 |
17 review(s) available for piperaquine and Infections, Plasmodium
| Article | Year |
|---|---|
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
Topics: Antimalarials; Drug Discovery; Humans; Malaria; Molecular Structure; Plasmodium | 2019 |
Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
Topics: Animals; Antimalarials; Artemisinins; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Structure; Paclitaxel; Quinolines | 2020 |
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana.
Topics: Antimalarials; Child; Drug Combinations; Ghana; Humans; Malaria; Malaria, Falciparum; Parasitemia; Treatment Outcome | 2022 |
Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trials.
Topics: Antimalarials; Drug Combinations; Female; Humans; Infant; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Vomiting | 2023 |
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations.
Topics: Amodiaquine; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Global Health; HIV Infections; Humans; Malaria; Malnutrition; Mefloquine; Models, Biological; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Vulnerable Populations | 2021 |
Intermittent preventive treatment for malaria in infants.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemisinins; Bias; Confidence Intervals; Disease Eradication; Drug Combinations; Endemic Diseases; Hospitalization; Humans; Infant; Malaria; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2021 |
Animal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Naphthyridines; Pregnancy; Pregnancy Trimester, First; Pyrimethamine; Quinine; Quinolines; Rabbits; Rats; Sulfadoxine; Teratogens | 2017 |
Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Bayes Theorem; Cause of Death; Cohort Studies; Drug Therapy, Combination; Female; Humans; Malaria; Mozambique; Prospective Studies; Quinolines | 2018 |
A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2019 |
Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2017 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Progress in the development of piperaquine combinations for the treatment of malaria.
Topics: Adult; Antimalarials; Artemisinins; Child; Clinical Trials as Topic; Drug Combinations; Humans; Malaria; Quinolines | 2009 |
Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic; Treatment Failure | 2013 |
Piperaquine: a resurgent antimalarial drug.
Topics: Animals; Antimalarials; Humans; Malaria; Quinolines | 2005 |
Quantification of the antimalarial piperaquine in plasma.
Topics: Animals; Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Malaria; Quinolines; Tandem Mass Spectrometry | 2008 |
67 trial(s) available for piperaquine and Infections, Plasmodium
| Article | Year |
|---|---|
Dihydroartemisinin-Piperaquine Chemoprevention and Malaria Incidence After Severe Flooding: Evaluation of a Pragmatic Intervention in Rural Uganda.
Topics: Adult; Antimalarials; Artemisinins; Chemoprevention; Child; Floods; Humans; Incidence; Malaria; Piperazines; Quinolines; Uganda | 2022 |
Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH
Topics: Antimalarials; Artemisinins; Drug Combinations; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Quinolines; Randomized Controlled Trials as Topic | 2021 |
Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
Topics: Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Piperazines; Placenta; Pregnancy; Pregnant Women; Quinolines; Uganda | 2022 |
Effect of dihydroartemisinin/piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Malaria; Oxazines; Piperazines; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyridones; Quinolines | 2022 |
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.
Topics: Aminoquinolines; Animals; Artemisinins; Humans; Malaria; Malaria, Falciparum; Mali; Piperazines; Plasmodium falciparum; Quinolines; Single-Blind Method | 2022 |
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemisinins; Chemoprevention; Child; Child, Preschool; Drug Combinations; Female; Humans; Hydroxyurea; Infant; Kenya; Malaria; Malaria, Falciparum; Male; Proguanil; Pyrimethamine; Sulfadoxine | 2022 |
Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV.
Topics: Antimalarials; Female; HIV Infections; Humans; Malaria; Pregnancy; Pregnant Women; Quinolines | 2022 |
Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial.
Topics: Adult; Animals; Anopheles; Artemisinins; Gambia; Humans; Ivermectin; Malaria; Mass Drug Administration; Mosquito Vectors | 2022 |
Implementation research of a cluster randomized trial evaluating the implementation and effectiveness of intermittent preventive treatment for malaria using dihydroartemisinin-piperaquine on reducing malaria burden in school-aged children in Tanzania: met
Topics: Antimalarials; Child; Drug Combinations; Humans; Malaria; Quinolines; Tanzania | 2023 |
Impact of population based indoor residual spraying with and without mass drug administration with dihydroartemisinin-piperaquine on malaria prevalence in a high transmission setting: a quasi-experimental controlled before-and-after trial in northeastern
Topics: Adolescent; Child; Cross-Sectional Studies; Humans; Insecticides; Malaria; Mass Drug Administration; Mosquito Control; Prevalence; Uganda | 2023 |
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-contro
Topics: Africa, Southern; Anemia, Sickle Cell; Antimalarials; Chemoprevention; Child; Drug Combinations; Humans; Malaria; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic | 2023 |
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Malaria, Vivax; Plasmodium vivax; Primaquine; Quinolines | 2023 |
Effectiveness and safety of intermittent preventive treatment with dihydroartemisinin-piperaquine or artesunate-amodiaquine for reducing malaria and related morbidities in schoolchildren in Tanzania: a randomised controlled trial.
Topics: Amodiaquine; Antimalarials; Artesunate; Child; COVID-19; Drug Combinations; Hemoglobins; Humans; Incidence; Malaria; Malaria, Falciparum; Quinolines; Tanzania | 2023 |
Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT).
Topics: Adolescent; Anemia; Antimalarials; Artemisinins; Child; Child, Preschool; Cluster Analysis; Drug Combinations; Female; Humans; Malaria; Male; Prevalence; Quinolines; Students; Uganda | 2019 |
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine versus single screening and treatment for the control of malaria in pregnancy in Papua, Indonesia: a provider perspective analysis from a cluster-randomised trial.
Topics: Adult; Antimalarials; Artemisinins; Cluster Analysis; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Quinolines | 2020 |
Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
Topics: Aftercare; Anemia; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Humans; Infant; Kenya; Malaria; Male; Patient Readmission; Quinolines; Uganda | 2020 |
Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the '
Topics: Adolescent; Antimalarials; Artemisinins; Drug Combinations; Humans; Immunity; Malaria; Quinolines; Randomized Controlled Trials as Topic; Uganda | 2021 |
Effectiveness of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaqunine Against Malaria in Pregnancy in Tanzania: A Randomized Controlled Trial.
Topics: Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Single-Blind Method; Tanzania; Treatment Outcome; Young Adult | 2021 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Eswatini; Humans; Malaria; Mass Drug Administration; Quinolines | 2021 |
The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Infant; Malaria; Malawi; Parasitemia; Piperazines; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Treatment Outcome | 2022 |
Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.
Topics: Adult; Antimalarials; Artemisinins; Double-Blind Method; Endpoint Determination; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Malaria; Pregnancy; Pregnancy Complications, Infectious; Quinolines; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda; Young Adult | 2017 |
Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Mefloquine; Pregnancy; Quinolines; Recurrence; Risk; Treatment Outcome; Young Adult; Zambia | 2017 |
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Longitudinal Studies; Malaria; Male; Naphthyridines; Quinolines; Young Adult | 2018 |
Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Cluster Analysis; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Female; Health Surveys; Humans; Malaria; Male; Prevalence; Quinolines; Residence Characteristics; School Health Services; Treatment Outcome; Uganda; Young Adult | 2018 |
Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial.
Topics: Anemia; Antimalarials; Artemisinins; Child, Preschool; Drug Administration Schedule; Humans; Infant; Malaria; Malawi; Medication Adherence; Quinolines | 2018 |
Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL).
Topics: Adult; Animals; Anopheles; Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Female; Humans; Insecticides; Ivermectin; Kenya; Long QT Syndrome; Malaria; Male; Quinolines; Treatment Outcome | 2019 |
Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, sup
Topics: Anemia; Artemisinins; Chemoprevention; Child, Preschool; Double-Blind Method; Drug Combinations; Humans; Infant; Infant, Newborn; Kenya; Malaria; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Sample Size; Uganda | 2018 |
A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.
Topics: Antimalarials; Artemisinins; Female; Humans; Incidence; Malaria; Male; Mass Drug Administration; Prevalence; Primaquine; Quinolines; Tanzania | 2018 |
Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers' perceptions and motivation.
Topics: Anemia; Antimalarials; Artemisinins; Attitude of Health Personnel; Caregivers; Chemoprevention; Child; Child, Preschool; Community Health Workers; Drug Combinations; Feasibility Studies; Female; Focus Groups; Government Programs; House Calls; Humans; Infant; Inservice Training; Malaria; Malawi; Male; Motivation; Patient Discharge; Perception; Qualitative Research; Quinolines; Workload | 2018 |
Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Asymptomatic Infections; Child; Child, Preschool; Cross-Sectional Studies; Disease Eradication; Female; Gambia; Humans; Infant; Infant, Newborn; Malaria; Male; Patient Acceptance of Health Care; Quinolines; Young Adult | 2019 |
Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria; Male; Quinolines; Rwanda | 2019 |
Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
Topics: Antimalarials; Artemisinins; Chemoprevention; Female; Follow-Up Studies; Humans; Infant; Malaria; Male; Plasma; Prospective Studies; Quinolines; Secondary Prevention; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2013 |
Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial.
Topics: Antimalarials; Child; Clinical Protocols; Congo; Drug Combinations; Drug Therapy, Combination; Ethics, Medical; Humans; Malaria; Pyrimethamine; Quinolines; Research Design; Sample Size; Sulfadoxine | 2013 |
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Child; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Parasitemia; Prevalence; Quinolines; Risk Factors; Uganda | 2014 |
Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children.
Topics: Antimalarials; Artemisinins; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lopinavir; Malaria; Male; Nevirapine; Parasitemia; Quinolines; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Uganda | 2014 |
Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Child; Female; Hemodynamics; Humans; Malaria; Male; Quinolines | 2014 |
Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
Topics: Adult; Antimalarials; Arrhythmias, Cardiac; Artemisinins; Double-Blind Method; Female; Humans; Malaria; Male; Quinolines; Young Adult | 2014 |
Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.
Topics: Antimalarials; Artemisinins; Cohort Studies; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Pyrimethamine; Quinolines; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2014 |
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
Topics: Antimalarials; Humans; Malaria; Male; Placebos; Quinolines; Thailand | 2014 |
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
Topics: Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Cohort Studies; Drug Combinations; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Quinolines; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2014 |
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial.
Topics: Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Birth Weight; Burkina Faso; Drug Combinations; Ethanolamines; Female; Fetal Development; Fluorenes; Follow-Up Studies; Ghana; Humans; Infant, Newborn; Malaria; Malawi; Mefloquine; Placentation; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Exposure Delayed Effects; Quinolines; Zambia | 2015 |
Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Utilization; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Malawi; Male; Medication Adherence; Quinolines; Surveys and Questionnaires | 2015 |
Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemisinins; Burkina Faso; Case-Control Studies; Chemoprevention; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Quinolines; Seasons; Sulfadoxine | 2015 |
Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomi
Topics: Antimalarials; Artemisinins; Catchment Area, Health; Child, Preschool; Community Health Services; Cross-Sectional Studies; Drug Combinations; Health Facilities; Humans; Incidence; Infant; Longitudinal Studies; Malaria; Mass Screening; Prevalence; Program Evaluation; Quinolines; Research Design; Seasons; Time Factors; Treatment Outcome; Zambia | 2015 |
Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Disease Transmission, Infectious; Female; Humans; Infant; Malaria; Male; Quinolines; Random Allocation; Treatment Outcome; Uganda; Young Adult | 2015 |
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-lab
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Female; Humans; Kenya; Malaria; Mass Screening; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Pyrimethamine; Quinolines; Risk Factors; Sulfadoxine; Treatment Outcome; Young Adult | 2015 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study.
Topics: Antimalarials; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Female; Heterocyclic Compounds, 1-Ring; Humans; India; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Male; Peroxides; Plasmodium falciparum; Quinolines; Rwanda; Spiro Compounds; Tablets | 2015 |
Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.
Topics: Adolescent; Adult; Aged; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Malaria, Vivax; Male; Maleates; Middle Aged; Peroxides; Quinolines; Spiro Compounds; Young Adult | 2016 |
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Incidence; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Uganda; Vomiting; Young Adult | 2016 |
User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Female; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Young Adult | 2016 |
Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Tr
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Diagnostic Tests, Routine; Drug Combinations; Female; Humans; Malaria; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2016 |
Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
Topics: Adolescent; Anemia; Antimalarials; Chemoprevention; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Hemoglobins; Humans; Malaria; Male; Parasitemia; Pyrimethamine; Quinolines; Schools; Students; Sulfadoxine; Treatment Outcome | 2017 |
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.
Topics: Adolescent; Adult; Alkynes; Antimalarials; Area Under Curve; Artemisinins; Benzoxazines; Chemoprevention; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Quinolines; Reverse Transcriptase Inhibitors; Uganda; Young Adult | 2017 |
Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
Topics: Antimalarials; Artemisinins; Child, Preschool; Cluster Analysis; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Pyrimethamine; Quinolines; Rural Population; Senegal; Sulfadoxine; Treatment Outcome | 2009 |
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Topics: Africa; Antiparasitic Agents; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors | 2009 |
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Quinolines; Risk; Uganda; Vomiting | 2010 |
Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria.
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Infant; Malaria; Malnutrition; Parasitemia; Quinolines | 2011 |
Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Child; Child, Preschool; Female; Humans; Malaria; Male; Quinolines | 2012 |
Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; DNA, Protozoan; Female; Humans; Indonesia; Malaria; Male; Middle Aged; Naphthoquinones; Parasitemia; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult | 2012 |
The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.
Topics: Adolescent; Adult; Amodiaquine; Animals; Artemisinins; Blood; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors; Treatment Outcome; Vietnam; Young Adult | 2012 |
Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance; Drug Therapy, Combination; Humans; Indonesia; Malaria; Malaria, Vivax; Male; Military Personnel; Plasmodium vivax; Primaquine; Quinine; Quinolines; Secondary Prevention | 2013 |
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Indonesia; Infant; Malaria; Male; Middle Aged; Prospective Studies; Quinolines; Sesquiterpenes; Survival Analysis; Treatment Outcome | 2007 |
[Observation on the efficacy of combined use of some new antimalarials for the treatment of falciparum malaria in Hainan Province].
Topics: Adolescent; Adult; Animals; Antimalarials; Drug Therapy, Combination; Female; Humans; Malaria; Male; Naphthyridines; Plasmodium falciparum; Quinazolines; Quinolines | 1989 |
[Comparative study of artemisinin suppositories and piperaquine phosphate in the treatment of falciparum malaria].
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Child; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes; Suppositories | 1989 |
102 other study(ies) available for piperaquine and Infections, Plasmodium
| Article | Year |
|---|---|
Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria.
Topics: Animals; Antimalarials; Chloroquine; Cyclohexylamines; Drug Resistance; Malaria; Molecular Conformation; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 1992 |
Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Therapy, Combination; Humans; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Sesquiterpenes; Treatment Outcome | 2008 |
Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Topics: Animals; Antimalarials; Biological Transport; Cell Line, Tumor; Chloroquine; Drug Resistance; Drug Therapy, Combination; Glutathione Reductase; Humans; In Vitro Techniques; Malaria; Mice; Mice, Inbred BALB C; Naphthalenes; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2008 |
In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Female; Humans; Indonesia; Malaria; Male; Middle Aged; Plasmodium malariae; Plasmodium ovale; Treatment Outcome; Young Adult | 2011 |
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Hep G2 Cells; Humans; Malaria; Mice; Plasmodium; Species Specificity; Structure-Activity Relationship | 2019 |
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Administration, Oral; Animals; Antimalarials; Cell Survival; Disease Models, Animal; Female; Half-Life; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Male; Mice; Mice, Inbred C57BL; Plasmodium falciparum; Structure-Activity Relationship | 2020 |
Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.
Topics: Animals; Antimalarials; Artemisinins; Gambia; Humans; Ivermectin; Malaria; Mass Drug Administration; Mosquito Vectors; Piperazines; Quinolines | 2022 |
Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine Combination at Primary Health Care
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Piperazines; Primary Health Care; Quinolines; Treatment Outcome | 2022 |
Artesunate and dihydroartemisinin-piperaquine treatment failure in a severe Plasmodium falciparum malaria case imported from Republic of Côte d'Ivoire.
Topics: Aged; Antimalarials; Artemisinins; Artesunate; Cote d'Ivoire; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Male; Piperazines; Plasmodium falciparum; Quinolines; Treatment Failure | 2022 |
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection | 2022 |
Antimalarial Efficacy of Aqueous Extract of Strychnos ligustrina and Its Combination with Dihydroartemisinin and Piperaquine Phosphate (DHP) against Plasmodium berghei Infection.
Topics: Animals; Antimalarials; Artemisinins; Malaria; Mice; Mice, Inbred BALB C; Phosphates; Plant Extracts; Plasmodium berghei; Strychnos | 2022 |
Therapeutic efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium vivax malaria in Seacha area, Arbaminch Zuria District, South West Ethiopia.
Topics: Antimalarials; Artemisinins; Ethiopia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax | 2022 |
Comparative efficacy of sulphadoxine-pyrimethamine and dihydroartemisinin-piperaquine against malaria infection during late-stage pregnancy in mice.
Topics: Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Malaria; Malaria, Falciparum; Mice; Plasmodium berghei; Pregnancy; Pyrimethamine | 2023 |
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection | 2023 |
Effectiveness of dihydroartemisinin-piperaquine after 10 years as treatment for vivax malaria in Indonesia.
Topics: Adult; Antimalarials; Child; Humans; Indonesia; Malaria; Malaria, Falciparum; Malaria, Vivax; Prospective Studies | 2023 |
A comprehensive approach to optimizing malaria prevention in pregnant women: evaluating the efficacy, cost-effectiveness, and resistance of IPTp-SP and IPTp-DP.
Topics: Antimalarials; Cost-Benefit Analysis; Female; Humans; Malaria; Pregnancy; Pregnant Women | 2023 |
Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia.
Topics: Antimalarials; DNA Copy Number Variations; Drug Resistance; Genetic Markers; Humans; Indonesia; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2023 |
Implementing population-based mass drug administration for malaria: experience from a high transmission setting in North Eastern Uganda.
Topics: Antimalarials; Artemisinins; Community Participation; Drug Combinations; Malaria; Mass Drug Administration; Quinolines; Uganda | 2019 |
Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Artemisinins; Drug Interactions; Drug Therapy, Combination; Female; Humans; Insecticides; Ivermectin; Malaria; Male; Middle Aged; Primaquine; Quinolines; Thailand; Young Adult | 2020 |
Intravenous artesunate plus oral dihydroartemisinin-piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Humans; Indonesia; Infant; Infant, Newborn; Malaria; Male; Middle Aged; Quinine; Quinolines; Retrospective Studies; Young Adult | 2019 |
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.
Topics: Animals; Antimalarials; Artemisinins; Burkina Faso; Child; Female; Humans; Incidence; Insecticides; Ivermectin; Malaria; Male; Mass Drug Administration; Mosquito Vectors; Prevalence; Quinolines; Randomized Controlled Trials as Topic; Seasons | 2020 |
Healthcare professionals' perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cross-Sectional Studies; Drug Resistance; Drug Therapy, Combination; Female; Health Personnel; Humans; Logistic Models; Malaria; Male; Patient Compliance; Plasmodium falciparum; Product Surveillance, Postmarketing; Quinolines; Sesquiterpenes; Surveys and Questionnaires; Tablets; Treatment Failure; Uganda | 2020 |
Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum Malaria.
Topics: Africa; Antimalarials; Child; Humans; Malaria; Malaria, Falciparum; Quinolines | 2020 |
Effect of mass dihydroartemisinin-piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance.
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Malaria; Mozambique; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinolines | 2020 |
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
Topics: Adult; Antimalarials; Artemisinins; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Therapeutics; Uganda; Young Adult | 2020 |
Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Diagnostic Tests, Routine; Drug Combinations; Feasibility Studies; Female; Humans; Kenya; Malaria; Mass Screening; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Quinolines; Young Adult | 2020 |
Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy.
Topics: Antimalarials; Drug Combinations; Female; Humans; Indonesia; Kenya; Malaria; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Quinolines | 2021 |
Understanding adherence to reactive treatment of asymptomatic malaria infections in The Gambia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Asymptomatic Infections; Child; Child, Preschool; Female; Gambia; Humans; Infant; Infant, Newborn; Malaria; Male; Medication Adherence; Patient Compliance; Plasmodium malariae; Quinolines; Young Adult | 2021 |
Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria.
Topics: Antimalarials; Australia; Humans; Malaria; Malaria, Falciparum; New Zealand; Plasmodium falciparum; Quinolines; Volunteers | 2021 |
A tablet derived from
Topics: Andrographis paniculata; Animals; Artemisinins; Female; Malaria; Mice; Mice, Inbred BALB C; Piperazines; Placenta; Pregnancy; Quinolines; Tablets | 2021 |
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines | 2021 |
Structure-switching aptamer sensors for the specific detection of piperaquine and mefloquine.
Topics: Antimalarials; Aptamers, Nucleotide; Humans; Malaria; Mefloquine; Quinolines | 2021 |
Isolation of Mutants With Reduced Susceptibility to Piperaquine From a Mutator of the Rodent Malaria Parasite
Topics: Animals; Antimalarials; Malaria; Malaria, Falciparum; Mice; Parasites; Plasmodium berghei; Plasmodium falciparum; Protozoan Proteins; Quinolines; Rodentia | 2021 |
Efficacy of dihydroartemisinin/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaoundé, Cameroon.
Topics: Antimalarials; Artemisinins; Cameroon; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines | 2021 |
Acute eosinophilic pneumonia following artenimol-piperaquine exposure.
Topics: Adult; Antimalarials; Artemisinins; Diagnosis, Differential; Humans; Malaria; Male; Pulmonary Eosinophilia; Quinolines; Tomography, X-Ray Computed; Travel | 2017 |
Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Parasitemia; Prevalence; Quinolines; Refugee Camps; Uganda | 2017 |
Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Resistance; Fluorescent Dyes; Genotype; Genotyping Techniques; Humans; Indoles; Inhibitory Concentration 50; Malaria; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Quinolines; Senegal; Young Adult | 2017 |
The application of physiologically based pharmacokinetic modelling to assess the impact of antiretroviral-mediated drug-drug interactions on piperaquine antimalarial therapy during pregnancy.
Topics: Alkynes; Antimalarials; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Malaria; Models, Biological; Population Groups; Pregnancy; Quinolines; Ritonavir; Serum Albumin, Human | 2017 |
Response to "Antiretroviral Therapy With Efavirenz in HIV-Infected Pregnant Women: Understanding the Possible Mechanisms for Drug-Drug Interaction".
Topics: Alkynes; Artemisinins; Benzoxazines; Chemoprevention; Cyclopropanes; Drug Interactions; Female; HIV; HIV Infections; Humans; Malaria; Pregnancy; Quinolines | 2018 |
Antiretroviral Therapy With Efavirenz in HIV-Infected Pregnant Women: Understanding the Possible Mechanisms for Drug-Drug Interaction.
Topics: Alkynes; Artemisinins; Benzoxazines; Chemoprevention; Cyclopropanes; Drug Interactions; Female; HIV; HIV Infections; Humans; Malaria; Pregnancy; Quinolines | 2018 |
Ivermectin: repurposing an old drug to complement malaria vector control.
Topics: Animals; Artemisinins; Double-Blind Method; Drug Repositioning; Ivermectin; Kenya; Malaria; Mosquito Vectors; Quinolines | 2018 |
Reappraising the cardiosafety of dihydroartemisinin-piperaquine.
Topics: Artemisinins; Bayes Theorem; Humans; Malaria; Quinolines | 2018 |
Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone.
Topics: Antimalarials; Artemisinins; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Mutation; Quinolines; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
High-dose ivermectin in malaria and other parasitic diseases: a new step in the development of a neglected drug.
Topics: Administration, Oral; Adult; Animals; Artemisinins; Double-Blind Method; Ivermectin; Kenya; Malaria; Parasitic Diseases; Quinolines; Scabies | 2018 |
Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study.
Topics: Adult; Anemia; Anti-Bacterial Agents; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Dietary Supplements; Erythromycin; Female; Folic Acid; Guideline Adherence; Health Personnel; HIV Infections; Humans; Iron, Dietary; Kenya; Laboratory Proficiency Testing; Longitudinal Studies; Malaria; Penicillins; Point-of-Care Testing; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Prenatal Care; Quinine; Quinolines; Syphilis; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
[Diagnosis and Treatment of the First Imported Case of Plasmodium knowlesi Infection in China].
Topics: Animals; Antimalarials; Artemisinins; China; Chloroquine; Erythrocytes; Hemeproteins; Humans; Malaria; Microscopy; Plasmodium knowlesi; Polymerase Chain Reaction; Primaquine; Quinolines; Trophozoites | 2016 |
Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Electrocardiography; Female; Healthy Volunteers; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mass Drug Administration; Middle Aged; Papua New Guinea; Patient Safety; Prospective Studies; Quinolines | 2018 |
Mass Drug Administration to Control and Eliminate Malaria in Africa: How Do We Best Utilize the Tools at Hand?
Topics: Africa; Artemisinins; Gambia; Humans; Malaria; Mass Drug Administration; Prospective Studies; Quinolines | 2019 |
Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Disease Transmission, Infectious; Female; Gambia; Health Services Research; Humans; Incidence; Infant; Malaria; Male; Mass Drug Administration; Middle Aged; Prevalence; Prospective Studies; Quinolines; Risk Assessment; Young Adult | 2019 |
Case Report: Birth Outcome and Neurodevelopment in Placental Malaria Discordant Twins.
Topics: Antimalarials; Artemisinins; Developmental Disabilities; Diseases in Twins; Female; Humans; Infant; Infant, Newborn; Malaria; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Premature Birth; Quinolines | 2019 |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
Topics: Artemisinins; Double-Blind Method; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pyrimethamine; Quinolines; Risk Assessment; Sulfadoxine | 2019 |
Clinical impact of the two ART resistance markers, K13 gene mutations and DPC3 in Vietnam.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Child; Child, Preschool; Drug Resistance; Female; Humans; Malaria; Male; Mutation; Plasmodium falciparum; Protozoan Proteins; Quinolines; Vietnam; Young Adult | 2019 |
[Descriptive study of malaria cases in the paediatric population in a reference hospital in Valencia, Spain, between 1993 and 2015].
Topics: Adolescent; Age Distribution; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Child, Preschool; Drug Combinations; Equatorial Guinea; Female; Hospitals, Community; Humans; Infant; Malaria; Male; Proguanil; Quinine; Quinolines; Retrospective Studies; Sex Distribution; Spain; Symptom Assessment | 2020 |
The unanticipated benefits of protecting young children from malaria.
Topics: Artemisinins; Child; Child, Preschool; Double-Blind Method; Humans; Malaria; Quinolines | 2019 |
Infectivity and Screening of Anti-piperaquine Genes in Mice Infected with Piperaquine-Sensitive and Piperaquine-Resistant Plasmodium berghei.
Topics: Animals; Antimalarials; Disease Models, Animal; Humans; Malaria; Male; Mice; Plasmodium berghei; Protozoan Proteins; Quinolines; Virulence | 2019 |
Devising a strategy for prevention of malaria in pregnant women in the Asia Pacific.
Topics: Artemisinins; Asia; Female; Humans; Indonesia; Malaria; Pregnancy; Quinolines | 2019 |
MMV in partnership: the Eurartesim® experience.
Topics: Adolescent; Adult; Artemisinins; Cambodia; Child; Child, Preschool; Drug Approval; Drug Combinations; Humans; Infant; Infant, Newborn; International Cooperation; Malaria; Public-Private Sector Partnerships; Quinolines | 2013 |
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cambodia; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Male; Mefloquine; Middle Aged; Plasma; Quinolines; Tanzania; Young Adult | 2013 |
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Computer Simulation; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Male; Quinolines; Treatment Outcome; Young Adult | 2014 |
Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysis.
Topics: Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Infant, Newborn; Malaria; Markov Chains; Outcome Assessment, Health Care; Quinolines | 2014 |
Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Combinations; Malaria; Mice; Parasite Load; Parasitic Sensitivity Tests; Plasmodium berghei; Quinolines; Recurrence | 2014 |
Protection against malaria by immunization with non-attenuated sporozoites under single-dose piperaquine-tetraphosphate chemoprophylaxis.
Topics: Animals; CD8-Positive T-Lymphocytes; Chemoprevention; Chloroquine; Disease Models, Animal; Female; Immunologic Memory; Liver; Malaria; Malaria Vaccines; Mice, Inbred C57BL; Plasmodium berghei; Quinolines; Spleen; Sporozoites | 2014 |
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Ethanolamines; Female; Fluorenes; Health Care Costs; Hospitals, District; Humans; Infant; Infant, Newborn; Malaria; Male; Models, Statistical; Quinolines; Tanzania; Treatment Outcome | 2014 |
Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Resistance; Ethanolamines; Fluorenes; Genetic Fitness; Lumefantrine; Malaria; Male; Mice; Plasmodium berghei; Quinolines | 2015 |
Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.
Topics: Antimalarials; Artemisinins; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Malaria; Prospective Studies; Quinolines; Uganda | 2015 |
Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
Topics: Adolescent; Adult; Africa; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Health Facilities; Heart Conduction System; Humans; Infant; Infant, Newborn; Longitudinal Studies; Malaria; Male; Middle Aged; Prospective Studies; Quinolines; Young Adult | 2015 |
Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Female; Humans; Indonesia; Infant, Newborn; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Young Adult | 2015 |
Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt.
Topics: Alleles; Chloroquine; Drug Resistance; Evolution, Molecular; French Guiana; Genetic Markers; Genome; Genotype; Haplotypes; Humans; Inhibitory Concentration 50; Malaria; Membrane Transport Proteins; Mutation; Phenotype; Plasmodium falciparum; Prevalence; Principal Component Analysis; Protozoan Proteins; Quinolines; Retrospective Studies | 2015 |
Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Care Costs; Humans; Infant; Malaria; Markov Chains; Models, Economic; Quinolines; Tanzania | 2016 |
Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Burkina Faso; Child; Child, Preschool; Female; Ghana; Health Facilities; Humans; Infant; Longitudinal Studies; Malaria; Male; Middle Aged; Mozambique; Quinolines; Tanzania; Treatment Outcome; Young Adult | 2016 |
Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in The Gambia.
Topics: Adolescent; Adult; Aged; Anthropology; Antimalarials; Artemisinins; Attitude to Health; Child; Child, Preschool; Decision Making; Drug Administration Schedule; Female; Follow-Up Studies; Gambia; Humans; Infant; Infant, Newborn; Malaria; Male; Medication Adherence; Middle Aged; Patient Compliance; Patient Education as Topic; Quinolines; Rural Health Services; Rural Population; Young Adult | 2016 |
Back on TRAC: New trial launched in bid to outpace multidrug-resistant malaria.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; India; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinolines | 2016 |
Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.
Topics: Antimalarials; Chemoprevention; Computer Simulation; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Models, Theoretical; Quinolines | 2016 |
The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Disease Eradication; Disease Transmission, Infectious; Female; Humans; Infant; Malaria; Male; Middle Aged; Myanmar; Patient Acceptance of Health Care; Pregnancy; Primaquine; Quinolines; Surveys and Questionnaires; Thailand; Young Adult | 2016 |
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Black People; Blood Cell Count; Blood Chemical Analysis; Burkina Faso; Child; Child, Preschool; Data Interpretation, Statistical; Electrocardiography; Female; Ghana; Heart; Hospitals, Public; Humans; Malaria; Male; Mozambique; Quinolines; Tanzania; Ventricular Dysfunction; Young Adult | 2016 |
Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Malaria; Mice; Mice, Inbred BALB C; Quinolines | 2017 |
Antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Therapy, Combination; Ethanolamines; Fats; Fluorenes; Humans; Lumefantrine; Malaria; Quinolines; Treatment Failure | 2009 |
Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Resistance; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Serial Passage | 2009 |
Piperaquine pharmacodynamics and parasite viability in a murine malaria model.
Topics: Animals; Antimalarials; Disease Models, Animal; Malaria; Male; Mice; Mice, Inbred BALB C; Plasmodium berghei; Quinolines | 2009 |
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue.
Topics: Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Blotting, Southern; Dose-Response Relationship, Drug; Ethanolamines; Fluorenes; Genetic Vectors; Germ Cells, Plant; Green Fluorescent Proteins; Luciferases; Lumefantrine; Malaria; Methylene Blue; Naphthyridines; Plasmodium falciparum; Quinolines; Sexual Development | 2011 |
Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Body Weight; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Malaria; Middle Aged; Myanmar; Nonlinear Dynamics; Population; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Software; Tandem Mass Spectrometry; Thailand; Young Adult | 2012 |
Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dapsone; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Meta-Analysis as Topic; Models, Statistical; Outcome Assessment, Health Care; Proguanil; Quinolines; Regression Analysis | 2012 |
[Immunological analysis of piperaquine-resistant murine model of Plasmodium berghei ANKA strain].
Topics: Animals; Cells, Cultured; Disease Models, Animal; Drug Resistance; Interferon-gamma; Lymphocytes; Malaria; Male; Mice; Mice, Inbred Strains; Nitric Oxide; Plasmodium berghei; Quinolines; Spleen | 2012 |
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Topics: Alleles; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Arylamine N-Acetyltransferase; Base Sequence; Cambodia; Cytochrome P-450 Enzyme System; Drug Combinations; Ethanolamines; Fluorenes; Gene Frequency; Humans; Isoenzymes; Malaria; Mefloquine; Pharmacogenetics; Polymorphism, Single Nucleotide; Quinolines; Sequence Analysis, DNA; Tanzania | 2013 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast].
Topics: Adolescent; Aged; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Resistance, Microbial; Humans; Madagascar; Malaria; Piperazines; Plasmodium falciparum; Quinolines | 1984 |
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. II. Study in two regions of the east coast].
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Child; Chloroquine; Drug Resistance, Microbial; Humans; Madagascar; Malaria; Piperazines; Plasmodium falciparum; Quinolines | 1984 |
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. III. Studies in three regions of the interior].
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; Madagascar; Malaria; Piperazines; Plasmodium falciparum; Quinolines | 1984 |
[Studies on piperaquine as long-acting antimalarial drug against Plasmodium berghei in mice].
Topics: Animals; Antimalarials; Chloroquine; Delayed-Action Preparations; Female; Malaria; Mice; Plasmodium berghei; Quinolines | 1982 |
[The antimalarial effects of piperaquine phosphate and sulphadoxine composite as tested in Hainan Island (author's transl)].
Topics: Antimalarials; Drug Combinations; Humans; Malaria; Quinolines; Sulfadoxine; Sulfanilamides | 1981 |
Field observations on the antimalarial piperaquine.
Topics: Adolescent; Adult; Antimalarials; Child; China; Humans; Malaria; Quinolines | 1982 |
[Studies on residual antimalarial activity of tripynadine in mice and monkeys].
Topics: Animals; Antimalarials; Macaca mulatta; Malaria; Mice; Naphthyridines; Plasmodium berghei; Plasmodium cynomolgi; Quinolines | 1993 |
Histopathological changes of Macaca mulatta infected with Plasmodium knowlesi.
Topics: Animals; Artemisinins; Artesunate; Macaca mulatta; Malaria; Monkey Diseases; Plasmodium knowlesi; Quinolines; Sesquiterpenes; Suppositories | 2001 |
Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine.
Topics: Animals; Antimalarials; Drug Resistance; Humans; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Quinolines | 1991 |
[In vivo sensitivity of Plasmodium falciparum to piperaquine phosphate assayed in Linshui and Baisha counties, Hainan Province].
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; China; Drug Resistance; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Quinolines | 1989 |
[Suppressive effect of 3 combinations of antimalarials against Plasmodium cynomolgi].
Topics: Animals; Antimalarials; Drug Therapy, Combination; Macaca mulatta; Malaria; Naphthyridines; Quinazolines; Quinolines | 1987 |
Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Humans; Infant; Madagascar; Malaria; Mefloquine; Microbial Sensitivity Tests; Middle Aged; Phenanthrenes; Piperazines; Plasmodium falciparum; Quinine; Quinolines | 1985 |
[In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of 2 years' study].
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; In Vitro Techniques; Madagascar; Malaria; Phenanthrenes; Piperazines; Plasmodium falciparum; Quinine; Quinolines | 1985 |
[Development of a piperaquine-resistant line of Plasmodium berghei K 173 strain].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Quinolines; Sesquiterpenes | 1985 |
[Sensitivity of Plasmodium falciparum to piperaquine in Baoting County, Hainan Island].
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; China; Drug Synergism; Gametogenesis; Humans; Malaria; Middle Aged; Plasmodium falciparum; Primaquine; Quinolines | 1985 |
[Resistance to piperaquine phosphate in Hainan islanders with pernicious malaria].
Topics: Adolescent; Adult; Animals; Antimalarials; Child; China; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Quinolines | 1985 |